Globalization and the pharmaceutical industry revisited

International Journal of Health Services

Volumn 33, Issue 3, 2003, Pages 581-605

  Busfield, Joan ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; AMLODIPINE PLUS BENAZEPRIL; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; BUDESONIDE; CELECOXIB; CLOPIDOGREL; CONJUGATED ESTROGEN; CYCLOSPORIN A; DOCETAXEL; ENOXAPARIN; FENTANYL; FEXOFENADINE; GENERIC DRUG; GLUCOPHAGE IR; LATANOPROST; LISINOPRIL; LOSARTAN POTASSIUM; METFORMIN; OMEPRAZOLE; PAROXETINE; PRAVASTATIN; RECOMBINANT ERYTHROPOIETIN; RISPERIDONE; ROFECOXIB; SERTRALINE; SIMVASTATIN; SUMATRIPTAN SUCCINATE; TOLTERODINE; UNINDEXED DRUG; VALSARTAN;

PHARMACEUTICAL INDUSTRY;

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; CULTURAL FACTOR; DRUG DEVELOPMENT; DRUG INDICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; ECONOMICS; GEOGRAPHIC DISTRIBUTION; GLOBALIZATION; INTERNATIONAL COOPERATION; REVIEW;

COMMERCE; DRUG INDUSTRY; DRUGS, GENERIC; ECONOMIC COMPETITION; HEALTH CARE SECTOR; HUMANS; INTELLECTUAL PROPERTY; INTERNATIONALITY; INVESTMENTS; WORLD HEALTH;

EID: 0141889897     PISSN: 00207314     EISSN: None     Source Type: Journal    
DOI: 10.2190/262X-56RG-M4T6-1GU5     Document Type: Review

References (32)

1. IMS Health. The IMS World Review 2001. Fairfield, Conn., 2002.
2. Association of British Pharmaceutical Industry. Facts & Statistics from the Pharmaceutical Industry. www.abpi.org.uk/statistics
3. Tarabusi, C., and Vickery, G. Globalization in the pharmaceutical industry, part I. Int. J. Health Serv. 28: 67-105, 1998.
4. Tarabusi, C., and Vickery, G. Globalization in the pharmaceutical industry, part II. Int. J. Health Serv. 28: 282-303, 1998.
5. OECD. Globalization of Industry: Overview and Sector Reports. Paris, 1996.
6. Thompson, J. N. The globalization of communication. In The Global Transformations Reader, ed. D. Held and A. McGrew. Polity, Cambridge, 2000.
7. Held, D., et al. Rethinking globalization. In The Global Transformations Reader, ed. D. Held and A. McGrew. Polity, Cambridge, 2000.
8. Harvey, D. The Condition of Postmodernity. Blackwell, Oxford, 1989.
9. Albrow, M. Introduction. In Globalisation, Knowledge, and Society, ed. M. Albrow and E. King. Sage, London, 1990.
10. Nederveen Pieterse, J. Globalization as hybridization. In Globalization: Critical Concepts, Analytical Perspectives, Vol. 1, ed. R. Robertsson and K. E. White. Routledge, London, 2002.
11. Hirst, P., and Thompson, G. Globalization in Question, Ed. 2. Polity, Cambridge, 1999.
12. Hatzichronoglou, T. The Globalization of Industry in the OECD Countries. STI Working Papers 1999/2. OECD, Paris, 1999.
13. Tomlinson, J. Cultural globalization: Placing and displacing the west. In The Media Reader: Continuity and Transformation, ed. H. Mackay and T. O'Sullivan. Sage, London, 1999.
14. Pfizer. Press release, July 15, 2002.
15. AstraZeneca. Annual Report 2001. London, 2002.
16. GlaxoSmithKline. Annual Report 2001. London, 2002.
17. Johnson & Johnson. Annual Report 2001. New Brunswick, N.J., 2002.
18. Merck & Co. Annual Report 2001. Whitehouse Station, N.J., 2002.
19. Aventis. Annual Report 2001. Strasbourg, 2002.
20. Strong medical and drugs sales boost for J&J. Financial Times, July 17, 2002.
21. Pharmaceutical Manufacturers of America. Pharmaceutical Industry Profile 2001. Washington, D.C., 2001.
22. Novartis. Annual Report 2001. Basel, 2002.
23. Brichacek, A., and Sellers, L. J. Flexing their budgets: Big pharma spend trends. Pharmaceutical Executive, September 2001.
24. Jaffe, S. Biotech-BigPharma betrothals declining. Scientist 16: 57, July 8, 2002.
25. IMS Health. Growth in New Active Substances (NASs): How Biotechnology Drugs are Making Inroads. www.imshealth.com
26. Gibbs, G. Pfizer gives cactus drug green light. Guardian (Manchester), July 31, 2002.
27. U.S. Food and Drug Administration, Committee for Drug Evaluation and Review. New and Generic Drug Approvals: 1998-2002. www.fda.gov/cder/approval/index.htm
28. World Trade Organization. TRIPS and Pharmaceutical Patents. Fact sheet. Washington, D.C., April 2001.
29. Generic Pharmaceutical Association. Generic Market Share. www.gphaonline.org/news/index
30. IMS Health. IMS Health Data Reveal Dramatic Growth in "Megabrands." www.imshealth.com
31. Marks, L. V. Sexual Chemistry: A History of the Contraceptive Pill. Yale University Press, New Haven, 2001.
32. Medawar, C. The antidepressant web: Marketing depression and making medicines work. Int. J. Risk Safety Med. 10: 75-126, 1997.